Bevacizumab suppresses choroidal neovascularization secondary to pathologic myopia: A pilot study

被引：0
|
作者：
Nguyen, QD
Shah, SM
Tatlipinar, S
Do, DV
Van Anden, E
Campochiaro, PA
机构：
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2005年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
1379
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Intravitreal bevacizumab for choroidal neovascularization due to pathologic myopia: long-term outcomes
    Sarao, Valentina
    Veritti, Daniele
    Macor, Sara
    Lanzetta, Paolo
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2016, 254 (03) : 445 - 454
  • [22] Intravitreal Bevacizumab Treatment for Choroidal Neovascularization in Pathologic Myopia: 12-month Results
    Gharbiya, Magda
    Allievi, Francesca
    Mazzeo, Luigi
    Gabrieli, Corrado Balacco
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2009, 147 (01) : 84 - 93
  • [23] Intravitreal bevacizumab for choroidal neovascularization due to pathologic myopia: long-term outcomes
    Valentina Sarao
    Daniele Veritti
    Sara Macor
    Paolo Lanzetta
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2016, 254 : 445 - 454
  • [24] Characteristics of Periconus Choroidal Neovascularization in Pathologic Myopia
    Nagaoka, Natsuko
    Shimada, Noriaki
    Hayashi, Wakako
    Hayashi, Kengo
    Moriyama, Muka
    Yoshida, Takeshi
    Tokoro, Takashi
    Ohno-Matsui, Kyoko
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2011, 152 (03) : 420 - 427
  • [25] Infographic: A randomized controlled study of ranibizumab in patients with choroidal neovascularization secondary to pathologic myopia: the RADIANCE study
    Yusuf, Imran H. H.
    Henein, Christin
    Sivaprasad, Sobha
    EYE, 2024, 38 (SUPPL 2) : 28 - 30
  • [26] Circulating hematopoietic stem cells in patients with choroidal neovascularization secondary to pathologic myopia
    Sasahara, M.
    Otani, A.
    Yodoi, Y.
    Gotoh, N.
    Kameda, T.
    Yoshimura, N.
    EYE, 2009, 23 (03) : 718 - 726
  • [27] Circulating hematopoietic stem cells in patients with choroidal neovascularization secondary to pathologic myopia
    M Sasahara
    A Otani
    Y Yodoi
    N Gotoh
    T Kameda
    N Yoshimura
    Eye, 2009, 23 : 718 - 726
  • [28] CANADIAN BURDEN OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO PATHOLOGIC MYOPIA: BASELINE CHARACTERISTICS OF PATIENTS
    Zaour, N.
    Heisel, O.
    Barbeau, M.
    Ma, P.
    VALUE IN HEALTH, 2013, 16 (07) : A504 - A504
  • [29] TWO-YEAR OUTCOMES OF INTRAVITREAL BEVACIZUMAB FOR CHOROIDAL NEOVASCULARIZATION IN JAPANESE PATIENTS WITH PATHOLOGIC MYOPIA
    Hayashi, Kengo
    Shimada, Noriaki
    Moriyama, Muka
    Hayashi, Wakako
    Tokoro, Takashi
    Ohno-Matsui, Kyoko
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2012, 32 (04): : 687 - 695
  • [30] Intravitreal Bevacizumab for Extrafoveal Choroidal Neovascularization Associated With Pathologic Myopia: 24-Month Outcomes
    Kontadakis, D.
    Parodi, M. Battaglia
    Pece, A.
    Iacono, P.
    Papayannis, A.
    Zucchiatti, I.
    Cascavilla, M.
    Bandello, F.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
12345